Show Summary Details
Page of

Neurological drugs 

Neurological drugs
Chapter:
Neurological drugs
Author(s):

Carl Waldmann

, Andrew Rhodes

, Neil Soni

, and Jonathan Handy

DOI:
10.1093/med/9780198723561.003.0014
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 21 October 2021

This chapter discusses neurological drugs and includes discussion on opioid and non-opioid analgesics in the intensive care unit (ICU; describing usage of opioid analgesics and non-opioid analgesics), sedation management in the ICU (including sedative agents), muscle relaxants (discussing physiology, depolarizing blockers, non-depolarizing blockers, the suxamethonium versus rocuronium debate, clinical use of prolonged muscular blockade, monitoring, problems, and complications), antiepileptic drugs (first-, second-, third-line drugs), neuroprotective agents (pharmacological neuroprotection and hypothermia), and mannitol and hypertonic saline. It aims to provide a summary of neurological and neuromuscular drugs commonly used in the ICU, although it is not exhaustive. Owing to variations in formulations and bioequivalence, drug doses should always be checked against local protocols before being administered to patients.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.